JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grocott, H. P.
Right arrow Articles by Mackensen, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grocott, H. P.
Right arrow Articles by Mackensen, G. B.

Anesth Analg 2005;100:1869-1870
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000156712.21918.BD


LETTER TO THE EDITOR

Apolipoprotein E Genotype and S100ß After Cardiac Surgery: Is Inflammation the Link?

Hilary P. Grocott, MD, FRCPC, and G. Burkhard Mackensen, MD

Department of Anesthesiology, Duke University Medical Center, Durham, NC, h.grocott{at}duke.edu

To the Editor:

The recent report by Kofke et al. (1) outlining a relationship between apolipoprotein E genotype and serum markers of "cerebral injury" after cardiac surgery raises some interesting issues. At first glance, the hypothesis that biochemical markers of brain injury after cardiac surgery demonstrate larger increases in patients possessing the Apo{epsilon}4 allele, an allele previously associated with worse neurologic outcome after cardiac surgery, (2) seems logical. However, their explanation that this relationship relates to the increased susceptibility of Apo{epsilon}4 patients to cerebral ischemia during major vascular and cardiac surgery has some inherent flaws. The weakness in this argument stems from the fact that extracerebral sources for S100ß have been identified; mediastinal blood aspirated by cardiotomy suction has been shown to have high concentrations of S100ß (3). As a result, the use of the cardiotomy grossly contaminates the blood with S100ß, making serum levels an unreliable surrogate of cerebral injury. Furthermore, the recent work by Fazio et al. has largely explained the true reason for the apparent extracerebral source for S100ß (4). The commercially available assays used by Kofke et al. and others lack sufficient specificity for S100ß, with the S100ß signal representing other high molecular proteins (such as heptaglobin precursor I).

However, this does leave the question as to how the authors found this apparent relationship. A potential, although admittedly not exclusive, explanation for this may lie in an enhanced inflammatory response to cardiopulmonary bypass previously demonstrated in Apo{epsilon}4-positive patients (5). An augmented inflammatory response may lead to increased bleeding (6) and if the Apo{epsilon}4 patients bled more, they likely would have had more mediastinal and pericardial blood (with high S100ß levels) returning to the venous reservoir via the cardiotomy suction and, as a result, have higher blood levels of S100ß (7). Therefore, the link between S100ß and Apo{epsilon}4 is most likely unrelated to cerebral injury per se but may represent an indirect link to an enhanced inflammatory response.

References

  1. Kofke WA, Konitzer P, Meng QC, et al. The effect of apolipoprotein E genotype on neuron-specific enolase and S-100ß levels after cardiac surgery. Anesth Analg 2004;99:1323–5.[Abstract/Free Full Text]
  2. Tardiff B, Newman M, Saunders A, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. Ann Thorac Surg 1997;64:715–20.[Abstract/Free Full Text]
  3. Anderson RE, Hansson LO, Liska J, et al. The effect of cardiotomy suction on the brain injury marker S100ß after cardiopulmonary bypass. Ann Thorac Surg 2000;69:847–50.[Abstract/Free Full Text]
  4. Fazio V, Bhudia SK, Marchi N, et al. Peripheral detection of S100ß during cardiothoracic surgery: What are we really measuring? Ann Thorac Surg 2004;78:46–52.[Abstract/Free Full Text]
  5. Grocott HP, Newman MF, El-Moalem H, et al. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001;122:622–3.[Free Full Text]
  6. Tassani P, Augustin N, Barankay A, et al. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000;14:682–6.[Web of Science][Medline]
  7. Grocott HP, Arrowsmith JE. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2001;86:289–90.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grocott, H. P.
Right arrow Articles by Mackensen, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grocott, H. P.
Right arrow Articles by Mackensen, G. B.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press